A triple growth factor strategy for optimizing bone augmentation in mice
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2024
DOI: 10.1002/jbm.b.35447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2024. Verfasst von Taichi Tenkumo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Advanced Prosthetic Dentistry, Tohoku University Graduate school of Dentistry, Sendai, Japan. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Insulin-Like Growth Factor I, Vascular Endothelial Growth Factor A. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
With dental implant treatment becoming the gold standard, the need for effective bone augmentation prior to implantation has grown. This study aims to evaluate a bone augmentation strategy integrating three key growth factors: bone morphogenetic protein‐2 (BMP‐2), insulin‐like growth factor 1 (IGF‐1), and vascular endothelial growth factor (VEGF). Collagen scaffolds incorporating BMP‐2, IGF‐1, or VEGF were fabricated and categorized into five groups based on their content: scaffold alone; BMP‐2 alone (BMP‐2); BMP‐2 and IGF‐1 (BI); BMP‐2, IGF‐1, and VEGF (BIV); and BMP‐2 and IGF‐1 with an earlier release of VEGF (BI + V). The prepared scaffolds were surgically implanted into the calvarias of C57BL/6JJcl mice, and hard tissue formation was assessed after 10 and 28 days through histological, tomographic, and biochemical analyses. The combination of BMP‐2 and IGF‐1 induced a greater volume of hard tissue augmentation compared with that of BMP‐2 alone, regardless of VEGF supplementation, and these groups had increased levels of cartilage compared with others. The volume of hard tissue formation was greatest in the BIV group. In contrast, the BI + V group exhibited a hard tissue volume similar to that of the BI group. While VEGF and CD31 levels were highest in the BIV group at 10 days, there was no correlation at the same time point between hard tissue formation and the quantity of M2 macrophages. In conclusion, the simultaneous release of BMP‐2, IGF‐1, and VEGF proved to be effective in promoting bone augmentation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Advanced Prosthetic Dentistry, Tohoku University Graduate school of Dentistry, Sendai, Japan.
- Department of Periodontology and Endodontology, Tohoku University Graduate School of Dentistry, Sendai, Japan.
- Department of Advanced Free Radical Science, Tohoku University Graduate School of Dentistry, Sendai, Japan.
- Tohoku University Graduate School of Dentistry, Sendai, Japan.
ORCID-Profile: Taichi Tenkumo
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tenkumo, T., Koide, R., Ogawa, T., Yamaguchi, H., Suzuki, S., Miyashita, M., Nakamura, K., Wang, H., Yoda, N., & Sasaki, K. (2024). A triple growth factor strategy for optimizing bone augmentation in mice. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35447
Vancouver
Tenkumo T, Koide R, Ogawa T, Yamaguchi H, Suzuki S, Miyashita M, et al. A triple growth factor strategy for optimizing bone augmentation in mice. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2024. doi:10.1002/jbm.b.35447
BibTeX
@article{Tenkumo2024,
author = {Tenkumo, Taichi and Koide, Rie and Ogawa, Toru and Yamaguchi, Hirofumi and Suzuki, Shigeki and Miyashita, Makiko and Nakamura, Keisuke and Wang, Han and Yoda, Nobuhiro and Sasaki, Keiichi},
title = {A triple growth factor strategy for optimizing bone augmentation in mice},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2024},
doi = {10.1002/jbm.b.35447}
}
EUVIMED